Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Language
Publication year range
1.
Gene Ther ; 30(1-2): 107-114, 2023 02.
Article in English | MEDLINE | ID: mdl-35581402

ABSTRACT

Mucopolysaccharidosis IVA (MPS IVA) is a lysosomal storage disorder (LSD) caused by mutations in gene encoding for GALNS enzyme. Lack of GALNS activity leads to the accumulation of glycosaminoglycans (GAGs) keratan sulfate and chondroitin 6-sulfate. Although enzyme replacement therapy has been approved since 2014 for MPS IVA, still there is an unmet medical need to have improved therapies for this disorder. CRISPR/Cas9-based gene therapy has been tested for several LSDs with encouraging findings, but to date it has not been assayed on MPS IVA. In this work, we validated for the first time the use of CRISPR/Cas9, using a Cas9 nickase, for the knock-in of an expression cassette containing GALNS cDNA in an in vitro model of MPS IVA. The results showed the successful homologous recombination of the expression cassette into the AAVS1 locus, as well as a long-term increase in GALNS activity reaching up to 40% of wild-type levels. We also observed normalization of lysosomal mass, total GAGs, and oxidative stress, which are some of the major findings regarding the pathophysiological events in MPS IVA. These results represent a proof-of-concept of the use of CRISPR/Cas9 nickase strategy for the development of a novel therapeutic alternative for MPS IVA.


Subject(s)
Chondroitinsulfatases , Mucopolysaccharidosis IV , Humans , Mucopolysaccharidosis IV/genetics , Mucopolysaccharidosis IV/therapy , CRISPR-Cas Systems , Gene Editing , Chondroitinsulfatases/genetics , Chondroitinsulfatases/metabolism , Chondroitinsulfatases/therapeutic use , Keratan Sulfate/metabolism , Keratan Sulfate/therapeutic use , Glycosaminoglycans/genetics , Glycosaminoglycans/metabolism
2.
Glycoconj J ; 36(2): 165-174, 2019 04.
Article in English | MEDLINE | ID: mdl-30963354

ABSTRACT

Retinal degenerative diseases, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), are major causes of blindness worldwide. Humans cannot regenerate retina, however, axolotl (Ambystoma mexicanum), a laboratory-bred salamander, can regenerate retinal tissue throughout adulthood. Classic signaling pathways, including fibroblast growth factor (FGF), are involved in axolotl regeneration. Glycosaminoglycan (GAG) interaction with FGF is required for signal transduction in this pathway. GAGs are anionic polysaccharides in extracellular matrix (ECM) that have been implicated in limb and lens regeneration of amphibians, however, GAGs have not been investigated in the context of retinal regeneration. GAG composition is characterized native and decellularized axolotl and porcine retina using liquid chromatography mass spectrometry. Pig was used as a mammalian vertebrate model without the ability to regenerate retina. Chondroitin sulfate (CS) was the main retinal GAG, followed by heparan sulfate (HS), hyaluronic acid, and keratan sulfate in both native and decellularized axolotl and porcine retina. Axolotl retina exhibited a distinctive GAG composition pattern in comparison with porcine retina, including a higher content of hyaluronic acid. In CS, higher levels of 4- and 6- O-sulfation were observed in axolotl retina. The HS composition was greater in decellularized tissues in both axolotl and porcine retina by 7.1% and 15.4%, respectively, and different sulfation patterns were detected in axolotl. Our findings suggest a distinctive GAG composition profile of the axolotl retina set foundation for role of GAGs in homeostatic and regenerative conditions of the axolotl retina and may further our understanding of retinal regenerative models.


Subject(s)
Chondroitin Sulfates/analysis , Heparitin Sulfate/analysis , Hyaluronic Acid/analysis , Keratan Sulfate/analysis , Retina/chemistry , Ambystoma mexicanum , Animals , Chondroitin Sulfates/metabolism , Heparitin Sulfate/metabolism , Hyaluronic Acid/metabolism , Keratan Sulfate/metabolism , Retina/metabolism , Swine
3.
Eur Respir J ; 40(6): 1362-73, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22496324

ABSTRACT

Extracellular matrix (ECM) composition has an important role in determining airway structure. We postulated that ECM lung composition of chronic obstructive pulmonary disease (COPD) patients differs from that observed in smoking and nonsmoking subjects without airflow obstruction. We determined the fractional areas of elastic fibres, type-I, -III and -IV collagen, versican, decorin, biglycan, lumican, fibronectin and tenascin in different compartments of the large and small airways and lung parenchyma in 26 COPD patients, 26 smokers without COPD and 16 nonsmoking control subjects. The fractional area of elastic fibres was higher in non-obstructed smokers than in COPD and nonsmoking controls, in all lung compartments. Type-I collagen fractional area was lower in the large and small airways of COPD patients and in the small airways of non-obstructed smokers than in nonsmokers. Compared with nonsmokers, COPD patients had lower versican fractional area in the parenchyma, higher fibronectin fractional area in small airways and higher tenascin fractional area in large and small airways compartments. In COPD patients, significant correlations were found between elastic fibres and fibronectin and lung function parameters. Alterations of the major ECM components are widespread in all lung compartments of patients with COPD and may contribute to persistent airflow obstruction.


Subject(s)
Extracellular Matrix/metabolism , Pulmonary Disease, Chronic Obstructive/metabolism , Adult , Aged , Biglycan/metabolism , Case-Control Studies , Chondroitin Sulfate Proteoglycans/metabolism , Collagen/metabolism , Decorin/metabolism , Female , Fibronectins/metabolism , Humans , Immunohistochemistry/methods , Keratan Sulfate/metabolism , Lumican , Lung/metabolism , Lung/surgery , Male , Middle Aged , Respiratory Function Tests , Smoking/adverse effects , Tenascin/metabolism
4.
J Anat ; 216(1): 144-55, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19900179

ABSTRACT

In the pregnant mouse endometrium, collagen fibrillogenesis is characterized by the presence of very thick collagen fibrils which are topographically located exclusively within the decidualized stroma. This dynamic biological process is in part regulated by the small leucine-rich proteoglycans decorin and biglycan. In the present study we utilized wild-type (Dcn(+/+)) and decorin-deficient (Dcn(-/-)) time-pregnant mice to investigate the evolution of non-decidualized and decidualized collagen matrix in the uterine wall of these animals. Ultrastructural and morphometric analyses revealed that the organization of collagen fibrils in the pregnant endometrium of both non-decidualized and decidualized stroma showed a great variability of shape and size, regardless of the genotype. However, the decidualized endometrium from Dcn(-/-) mice contained fibrils with larger diameter and more irregular contours as compared to the wild-type littermates. In the Dcn(-/-) animals, the proportion of thin (10-50 nm) fibrils was also higher as compared to Dcn(+/+) animals. On day 7 of pregnancy, biglycan was similarly localized in the decidualized endometrium in both genotypes. Lumican immunostaining was intense both in decidualized and non-decidualized stroma from Dcn(-/-) animals. The present results support previous findings suggesting that decorin participates in uterine collagen fibrillogenesis. In addition, we suggest that the absence of decorin disturbs the process of lateral assembly of thin fibrils, resulting in very thick collagen fibrils with irregular profiles. Our data further suggest that decorin, biglycan and lumican might play an interactive role in collagen fibrillogenesis in the mouse endometrium, a process modulated according to the stage of pregnancy.


Subject(s)
Endometrium/ultrastructure , Extracellular Matrix Proteins/deficiency , Fibrillar Collagens/ultrastructure , Proteoglycans/deficiency , Animals , Biglycan , Chondroitin Sulfate Proteoglycans/metabolism , Chondroitin Sulfate Proteoglycans/physiology , Decidua/ultrastructure , Decorin , Endometrium/metabolism , Extracellular Matrix Proteins/metabolism , Extracellular Matrix Proteins/physiology , Female , Keratan Sulfate/metabolism , Keratan Sulfate/physiology , Lumican , Mice , Mice, Knockout , Microscopy, Electron , Pregnancy , Proteoglycans/metabolism , Proteoglycans/physiology
5.
Braz J Med Biol Res ; 34(3): 325-31, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11262582

ABSTRACT

Corneal transparency is attributed to the regular spacing and diameter of collagen fibrils, and proteoglycans may play a role in fibrillogenesis and matrix assembly. Corneal scar tissue is opaque and this opacity is explained by decreased ultrastructural order that may be related to proteoglycan composition. Thus, the objectives of the present study were to characterize the proteoglycans synthesized by human corneal explants and to investigate the effect of mechanical epithelial debridement. Human corneas unsuitable for transplants were immersed in F-12 culture medium and maintained under tissue culture conditions. The proteoglycans synthesized in 24 h were labeled metabolically by the addition of (35)S-sulfate to the medium. These compounds were extracted by 4 M GuHCl and identified by a combination of agarose gel electrophoresis, enzymatic degradation with protease and mucopolysaccharidases, and immunoblotting. Decorin was identified as the main dermatan sulfate proteoglycan and keratan sulfate proteoglycans were also prominent components. When the glycosaminoglycan side chains were analyzed, only keratan sulfate and dermatan sulfate were detected (approximately 50% each). Nevertheless, when these compounds were (35)S-labeled metabolically, the label in dermatan sulfate was greater than in keratan sulfate, suggesting a lower synthesis rate for keratan sulfate. (35)S-Heparan sulfate also appeared. The removal of the epithelial layer caused a decrease in heparan sulfate labeling and induced the synthesis of dermatan sulfate by the stroma. The increased deposit of dermatan sulfate proteoglycans in the stroma suggests a functional relationship between epithelium and stroma that could be related to the corneal opacity that may appear after epithelial cell debridement.


Subject(s)
Cornea/metabolism , Debridement , Proteoglycans/biosynthesis , Corneal Injuries , Corneal Stroma/metabolism , Debridement/adverse effects , Dermatan Sulfate/biosynthesis , Electrophoresis, Agar Gel , Extracellular Matrix , Glycosaminoglycans/biosynthesis , Glycosaminoglycans/isolation & purification , Heparitin Sulfate/metabolism , Humans , Keratan Sulfate/metabolism , Proteoglycans/isolation & purification , Stromal Cells/metabolism
6.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;34(3): 325-331, Mar. 2001. ilus
Article in English | LILACS | ID: lil-281612

ABSTRACT

Corneal transparency is attributed to the regular spacing and diameter of collagen fibrils, and proteoglycans may play a role in fibrillogenesis and matrix assembly. Corneal scar tissue is opaque and this opacity is explained by decreased ultrastructural order that may be related to proteoglycan composition. Thus, the objectives of the present study were to characterize the proteoglycans synthesized by human corneal explants and to investigate the effect of mechanical epithelial debridement. Human corneas unsuitable for transplants were immersed in F-12 culture medium and maintained under tissue culture conditions. The proteoglycans synthesized in 24 h were labeled metabolically by the addition of 35S-sulfate to the medium. These compounds were extracted by 4 M GuHCl and identified by a combination of agarose gel electrophoresis, enzymatic degradation with protease and mucopolysaccharidases, and immunoblotting. Decorin was identified as the main dermatan sulfate proteoglycan and keratan sulfate proteoglycans were also prominent components. When the glycosaminoglycan side chains were analyzed, only keratan sulfate and dermatan sulfate were detected (~50 percent each). Nevertheless, when these compounds were 35S-labeled metabolically, the label in dermatan sulfate was greater than in keratan sulfate, suggesting a lower synthesis rate for keratan sulfate. 35S-Heparan sulfate also appeared. The removal of the epithelial layer caused a decrease in heparan sulfate labeling and induced the synthesis of dermatan sulfate by the stroma. The increased deposit of dermatan sulfate proteoglycans in the stroma suggests a functional relationship between epithelium and stroma that could be related to the corneal opacity that may appear after epithelial cell debridement


Subject(s)
Humans , Cornea/metabolism , Debridement , Proteoglycans/biosynthesis , Corneal Stroma/metabolism , Cornea/injuries , Debridement/adverse effects , Dermatan Sulfate/biosynthesis , Electrophoresis, Agar Gel , Extracellular Matrix , Glycosaminoglycans/biosynthesis , Glycosaminoglycans/isolation & purification , Heparitin Sulfate/metabolism , Keratan Sulfate/metabolism , Proteoglycans/isolation & purification , Stromal Cells/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL